Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Chad has been on the rise in recent years.
Customer preferences: Chad has a high infant mortality rate, and vaccines are seen as a crucial tool in reducing this rate. As a result, there is a high demand for vaccines among parents of young children. Additionally, the government of Chad has been working to increase access to healthcare services, including vaccinations, for its citizens.
Trends in the market: One of the key trends in the vaccines market in Chad is the increasing availability of vaccines. The government of Chad has been working with international organizations to increase the availability of vaccines in the country, particularly in rural areas. This has led to an increase in the number of children who are vaccinated.Another trend in the market is the increasing use of combination vaccines. Combination vaccines allow for multiple vaccines to be given in a single shot, which can be particularly beneficial in areas where there is limited access to healthcare services.
Local special circumstances: Chad faces a number of challenges in delivering vaccines to its citizens. One of the biggest challenges is the country's poor infrastructure, particularly in rural areas. This can make it difficult to transport vaccines and to ensure that they are stored at the correct temperature.Another challenge is the country's high poverty rate. Many families in Chad struggle to afford healthcare services, including vaccines. As a result, the government has been working to increase access to free or low-cost vaccines for those who need them.
Underlying macroeconomic factors: Chad is one of the poorest countries in the world, with a low GDP per capita. This has implications for the vaccines market, as many families may struggle to afford vaccines for their children. However, the government of Chad has been working to increase access to healthcare services, including vaccines, for its citizens, which may help to offset some of these challenges. Additionally, international organizations have been working to increase the availability of vaccines in the country, which may help to make vaccines more affordable for families in Chad.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
